HDI Receives $822,000 in Proceeds From Exercise of Warrants

May 2, 2005

Hypertension Diagnostics announced that on April 29 it completed the issuance of 2,756,609 shares of common stock and 173,335 shares of Series A Convertible preferred stock to holders of warrants to purchase common stock and preferred stock, resulting in gross proceeds of $822,227, which represents 91 percent of the total warrant proceeds available for exercise.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqNwLWbWbmtiYCdKYmZm)